Sage Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.51) Per Share, Leerink Partnrs Forecasts (NASDAQ:SAGE)
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings estimates for shares of Sage Therapeutics in a research report issued on Wednesday, July 31st. Leerink Partnrs analyst M. Goodman now anticipates that the biopharmaceutical company will post earnings of ($1.51) per share for the quarter, up […]
More Stories
Third Coast Bancshares (NASDAQ:TCBX) Reaches New 52-Week High – Time to Buy?
Third Coast Bancshares, Inc. (NASDAQ:TCBX – Get Free Report)’s stock price reached a new 52-week high during trading on Monday...
First American Financial (NYSE:FAF) Reaches New 1-Year High – Time to Buy?
First American Financial Co. (NYSE:FAF – Get Free Report)’s stock price hit a new 52-week high on Monday . The...
National Bank of Canada (TSE:NA) Reaches New 52-Week High – Time to Buy?
National Bank of Canada (TSE:NA – Get Free Report)’s stock price reached a new 52-week high during trading on Monday...
Piper Sandler Companies (NYSE:PIPR) Hits New 1-Year High – Time to Buy?
Piper Sandler Companies (NYSE:PIPR – Get Free Report)’s share price hit a new 52-week high during trading on Monday ....
Qsemble Capital Management LP Purchases 2,956 Shares of Lockheed Martin Co. (NYSE:LMT)
Qsemble Capital Management LP boosted its holdings in Lockheed Martin Co. (NYSE:LMT – Free Report) by 64.8% during the 3rd...
Canton Hathaway LLC Purchases 500 Shares of Salesforce, Inc. (NYSE:CRM)
Canton Hathaway LLC increased its position in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 46.0% in the third...